MiraVista Diagnostics is an Industry Leading Mycology Reference Laboratory

MiraVista Diagnostics is a CLIA and CAP certified mycology reference laboratory (RL) with an exclusive focus on developing and processing diagnostic tests for serious fungal infections. We offer the highest standards in clinical accuracy and sensitivity for detection, monitoring and diagnostic testing for blastomyces dermatitidis, histoplasma capsulatum, cryptococcus, coccidioides, aspergillus and beta-D glucan.

Clinical Laboratory Testing for Serious Fungal Infections

The company was founded in 2002 by the renowned infectious disease scientist, Dr. Lawrence Joseph Wheat, whose groundbreaking research contributions resulted in the development of the first histoplasmosis antigen test in 1986. Today, MiraVista Diagnostics serves the medical and healthcare sectors in the U.S. and Canada processing over 100,000 tests per year for fungal infections. This includes antigen and antibody detection tests for coccidioides (valley fever fungus), aspergillus, histoplasmosis capsulatum, blastomyes dermatitidis and cryptococcus.

MiraVista Diagnostics offers same-day testing, prompt response, fast shipping and direct access to the laboratory’s team of experienced infectious disease specialists that has collectively published more than 1,000 scientific research articles. Clients include large medical research hospitals, healthcare systems and universities as well as large reference labs. Contact us to discuss a fungal infection case, set up a corporate account for high volume testing or order from among MiraVista Diagnostics’ menu of diagnostic screening tests for fungal diseases.

Company News

ALERT: Extreme Winter Weather May Delay Shipments to MiraVista’s Lab

Extreme winter weather conditions across the country could impact deliveries to MiraVista Diagnostics lab in Indianapolis, Indiana. Please check directly with your shipping carrier for alerts about weather-related service interruptions or delays that could impact your shipments to our lab….
READ MORE →

Happy New Year From Everyone at MiraVista Diagnostics

Everyone at MiraVista Diagnostics wishes you a Happy New Year!  We hope you had a wonderful holiday season and you’re just as excited to kick off 2019 as we are. HAPPY NEW YEAR MiraVista Diagnostics has an incredible team of…
READ MORE →

NIH Approved Institutional Biosafety Committee (IBC) Meeting Scheduled for January 14

In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….
READ MORE →

CDC Investigating Histoplasmosis Outbreak Among Boy Scout Campers in Baton Rouge

At least two Boy Scout campers have been diagnosed with histoplasmosis after staying at Camp Avondale in Baton Rouge, Louisiana.

MiraVista to Receive Economic Incentives from IEDC for Expansion Efforts

Indiana Economic Development Corporation Offers economic incentives to MiraVista Diagnostics. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.

MiraVista Diagnostics is Participating in 2018 ID Week in San Francisco

MiraVista Diagnostics is participating in 2018 ID Week in San Francisco on October 3-7, 2018. Visit us at booth #1032. Representatives from MiraVista will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal…
READ MORE →

ORDER TESTS
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo